Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Business Review
Thank you for Subscribing to Healthcare Business Review Weekly Brief
Stimlabs Expands Its Portfolio By Unveiling New Product Enverse
Patients are monitored using a patient monitoring system, which enables medical professionals to keep track of patients' health away from the hospital.
By
Healthcare Business Review | Thursday, August 11, 2022
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
StimLabs is expanding its product line to meet the increasing variety of needs in healthcare facilities.
FREMONT, CA: Patients are monitored using a patient monitoring system, which enables medical professionals to keep track of patients' health away from the hospital. It allows them to check the changes in a patient's health data in real-time and utilize that information to plan the patient's care and safety. Enverse, a new placental membrane-based product, is unveiled by StimLabs, one of the pioneers in regenerative technologies and products that are redefining patient care via innovation and customized solutions.
In response to a widening range of needs in healthcare facilities, StimLabs is expanding its product portfolio. Aiming to simplify patient care for both physicians and the hospital systems in which they practice, StimLabs unveiled Enverse. In addition to physician-owned facilities, hospitals also have access to StimLabs' solutions.